Navigation Links
Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics

ations for susceptibility testing (ECCMID/ICC07-P 1112) Researchers investigated whether polysorbate 80 (P80), a commonly used wetting agent, affects oritavancin (ORI) susceptibility test results. Testing the following both with and without P80, ORI and ciprofloxacin (CIP) were dissolved in water, diluted in cation-adjusted Mueller Hinton Broth (CAMHB) or CAMHB with two percent lysed horse blood (LHB), and dispensed into a microtiter plate for testing. Tests were conducted with Staphylococcus aureus (S. aureus), Enterococcus faecalis (E. faecalis) and Streptococcus pneumoniae (S. pneumoniae). S. aureus bacteria appear most commonly on the skin and nose, E. faecalis in the intestines, and S. pneumoniae in the nasal cavity, and all may lead to deadly infections.(1) Researchers found that without P80, ORI was rapidly lost from the solution, but inclusion of P80 or LHB promoted recovery of 80 to 100 percent of the agent for up to 24 hours. ORI minimal inhibitory concentrations (MICs) for S. aureus and E. faecalis were 16- to 32- fold lower in the presence of P80, compared with no MIC impact on vancomycin (VAN), teicoplanin (TEI) or CIP. ORI MICs for S. pneumoniae were identical with and without P80, likely as a result of LHB present in the microbiological culture medium for the pneumococcus. In addition, plates with low-binding surfaces demonstrated 4- to 8-fold reductions in ORI MICs without P80. These findings indicate that the addition of P80 to susceptibility tests minimizes ORI binding to plastic surfaces, which maintains ORI available in solution to stop growth of bacteria. Investigators also concluded that current literature on ORI MICs, without P80, may significantly underestimate its in vitro potency. -- Influence of po
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:9/19/2014)... 19, 2014 Research and Markets has ... Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to ... purposes of this report, the human microbiome market is segmented ... microbiome market is expected to be valued as $294 million ... of 22.3% within the forecast period of 2019-2023. The market ...
(Date:9/19/2014)... Mich. , Sept. 19, 2014  Diplomat, the ... of David Dreyer to the Board of ... independent director and will also serve as chair of ... almost 30 years of accounting, financial, compliance and operating ... Mr. Dreyer has served as chief financial officer, chief ...
(Date:9/19/2014)... , Sept. 19, 2014 Larry J. Merlo ... CVS ), will speak before the National Press Club in ... the company,s recent move to stop selling tobacco products and ... future of health. "Dramatic changes in our health ... providers and government," Merlo has said. "CVS Health has a ...
Breaking Medicine Technology:Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3David Dreyer Appointed to Diplomat Board of Directors 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... July 1 Watson Pharmaceuticals, Inc. (NYSE: WPI ... ) have approved the terms and conditions of the previously announced acquisition ... PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia ... , The ...
... SHENZHEN, China , July ... TCM ), a leading specialty,pharmaceutical company focusing on ... in China , today,announced that it filed its Annual ... 2009 with the Securities and Exchange Commission on ...
Cached Medicine Technology:Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets 2Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets 3Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets 4Tongjitang Files 2009 Annual Report on Form 20-F 2
(Date:9/20/2014)... Angeles, CA (PRWEB) September 20, 2014 ... score of 3.1 out of 5, indicating a moderately ... firm IBISWorld, this score reflects current and future pricing ... from historically high prices. Other factors that negatively affect ... in demand for construction and the moderate switching costs. ...
(Date:9/20/2014)... California (PRWEB) September 20, 2014 Final ... have announced the release of the Information theme for FCPX ... would use to describe the Information theme,” says Christina Austin, ... easy to look so professional.” , Information features easy to ... the parameters of the environment. Change the background color, color ...
(Date:9/20/2014)... September 20, 2014 MarijuanaDoctors.com recently ... showing at the PAIN Week conference that was ... and Casino in Las Vegas from September 2nd ... attended PAIN Week in the hopes of educating ... viable and legitimate tool to treat chronic Pain, ...
(Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing ... among patients with prescription drug coverage, may now be ... report from the Department of Health and Human ... laws prohibit suppliers from offering side-payments to increase sales ... , The report highlights that two recent surveys, including ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- As kids transition ... targets of cyberbullies, according to a recent study. ... 5 through 8 found that verbal and physical bullying ... vary, bullying intervention and prevention strategies must address all ... among boys and girls, the researchers said. The study ...
Breaking Medicine News(10 mins):Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2
... Safety Initiatives, DUBLIN, Ohio, Dec. 3 ... participating in the Institute for Healthcare,Improvement,s (IHI) 5 ... it is granting $537,000 to 37 hospitals that,enroll ... receive an average of,$15,000 each to help deepen ...
... COMPOUNDERS; ENABLES CONVENIENT, SECURE, VIRTUALLY ... OF CLASS II CONTROLLED SUBSTANCES, LAKE FOREST, ... provider of outsourced hospital compounded sterile preparations,announced a ... entire line of Schedule II Controlled Substances.,The initiative ...
... equipment, survey finds , , MONDAY, Dec. 3 (HealthDay News) -- ... nearest emergency room might want to keep a new finding ... United States have all the equipment they should have on ... to the survey, however, so the UCLA researchers suspect the ...
... income families and,uninsured individuals everywhere now have access ... prescription per month with delivery to their,home or ... new prescription assistance service,to those who qualify. It ... coverage, according to Doug Pierce, founder of the ...
... C-section has hit number one for,inpatient surgery in the ... Scarring, swelling, tenderness and surgical recovery are a,reality for ... Cesarean Underwear(TM) attempts to address the needs,of Cesarean moms ... of a C-section in mind. See http://www.cpanty.com ., ...
... Misys plc (FTSE: MSY.L),the global application software and services ... its Equation and Trade Innovation,solutions to support its expansion ... installed in its Hong Kong location since,2003, and have ... and,business for the bank. UCB concluded to expand the ...
Cached Medicine News:Health News:Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHI'S 5 Million Lives Campaign 2Health News:Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHI'S 5 Million Lives Campaign 3Health News:Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHI'S 5 Million Lives Campaign 4Health News:PharMEDium Announces Electronic 222 Ordering Initiative 2Health News:Most ERs Not Fully Prepared for Pediatric Patients 2Health News:Most ERs Not Fully Prepared for Pediatric Patients 3Health News:$7 Brand Name Prescriptions for Low Income and Un-Insured Avoid Prescription Discount Cards! 2Health News:Finally, Easy After-Cesarean Care for the 1.3 Million C-Section Moms 2Health News:United Commercial Bank Extends its Use of Misys' Equation and Trade Innovation Systems to Support its Expansion in Taiwan 2Health News:United Commercial Bank Extends its Use of Misys' Equation and Trade Innovation Systems to Support its Expansion in Taiwan 3
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
... Vivid i is the worlds ... high-performance, full-featured imaging in a lightweight design. ... addresses one of the biggest challenges in ... diagnostic information. The new system expands the ...
The Bio-Quant CK-MB test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of,CK-MB in human serum specimens as an aid in the diagnosis of myocar...
... with a diseased heart, the only therapy solution open ... However, donor organs are not always readily available. For ... on the waiting list for a donor organ. , ... the life of a patient. On the one hand, ...
Medicine Products: